Amsterdam Neuroscience
-
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
de Leeuw, D. M., Trieu, C., Vromen, E. M., Blujdea, E. R., Verberk, I. M. W., Duits, F. H., Teunissen, C. E., Pijnenburg, Y. A. L., van der Flier, W. M., van Harten, A. C., Visser, P. J. & Tijms, B. M., 1 Jul 2025, In: JAMA Network Open. 8, 7, p. e2519919Research output: Contribution to journal › Article* › Academic › peer-review
-
Plasma biomarkers for diagnosis and prognosis in Down syndrome-related Alzheimer's disease
Teunissen, C. & Duits, F., 1 Jul 2025, In: Lancet Neurol.. 24, 7, p. 561-562 2 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Assessing social cognition and risk-taking behaviour in patients with young-onset dementia: Study protocol for the YOD-RiSoCo observational prospective cohort study
YOD-INCLUDED Consortium, Gelmers, F., Huitema, R. B., Scheenen, M. E., van Munster, B. C., Spikman, J. M., Koopmans, R., de Heus, R., Salazar, A., Duits, F., Groeneveld, J., van den Berg, L., Vanneste, P., Ossenkoppele, R., van der Lee, S., Pijnenburg, Y., Blom, M., de Vries, H., de Vijlder, L. & Muller, L. & 31 others, , 1 May 2025, In: PLoS ONE. 20, 5 May, e0324517.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications